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Edited by Hans EklundAbstract There is great interest in the structure of adiponectin
as its oligomeric state may specify its biological activities. It
occurs as a trimer, a hexamer and a high molecular weight com-
plex. Epidemiological data indicate that the high molecular
weight form is signiﬁcant with low serum levels in type 2 diabet-
ics but to date, has not been well-deﬁned. To resolve this issue,
characterization of this oligomer from bovine serum and 3T3-
L1 adipocytes by sedimentation equilibrium centrifugation and
gel electrophoresis respectively, was carried out, revealing that
it is octadecameric. Further studies by dynamic light scattering
and electron microscopy established that bovine and possibly
mouse high molecular weight adiponectin is C1q-like in struc-
ture.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Collagen1. Introduction
Adiponectin is an adipocyte-derived hormone that has
broad eﬀects on whole body metabolism, from improving insu-
lin sensitivity in the liver [1] to fatty acid oxidation in skeletal
muscle [2], through the activation of AMP-activated protein
kinase (AMPK) [3,4]. This adipokine is processed into at least
three homomeric complexes, trimer, hexamer and ‘‘high
molecular weight’’ (HMW) forms [5,6] and bears similarities
in domain structure to the complement protein C1q [7]. There
is growing interest in the role of these complexes in metabolism
and disease as several lines of evidence suggest that oligomeric
state aﬀects the biological activity of adiponectin. At the
molecular level, T-cadherin, an adiponectin receptor or
co-receptor, shows selectivity in binding the hexamer and
HMW forms, but not trimer [8]. Experiments using cell-based
assays have also revealed diﬀerences in activity with oligomeric
state, from activation of AMPK in skeletal muscle [9] to sup-
pression of hepatic glucose output [6]. The ‘‘low molecular
weight’’ form (probably a hexamer) reduces lipopolysaccha-
ride-induced secretion of interleukin-6, which may form the
basis for the anti-inﬂammatory properties of adiponectin
[10]. Adiponectin has also been reported to mitigate endothe-
lial cell apoptosis [11], and cell proliferation [12] in an oligo-
meric state-dependent manner. Physiologically, the sexual*Corresponding author. Fax: +1 617 627 3443.
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doi:10.1016/j.febslet.2007.01.046dimorphism with respect to complex distribution of adiponec-
tin [6,13–17] has also been cited in connection with the possible
signiﬁcance of oligomeric state.
Recent studies are revealing that HMW adiponectin in par-
ticular is signiﬁcant as it correlates well with various metabolic
disorders. Type II diabetics have a low percentage of HMW
adiponectin relative to total adiponectin (the SA index) com-
pared to healthy individual [18]. Furthermore, thiazolidinedi-
ones, a class of antidiabetic drugs, improves this ratio.
Follow-up work revealed that adiponectin knockout mice do
not beneﬁt from thiazolidinediones as do wild type mice [1].
These studies imply that the SA index may be a good marker
for diabetes and that the antidiabetic action of thiazolidinedi-
ones involves HMW adiponectin. Furthermore, the SA index
correlates tightly to glucose intolerance in non-diabetic Indo-
Asian males [19], as well as with phenotypes associated with
metabolic syndrome [20]. This trend continues in subjects
who suﬀer from more advanced metabolic disorders [21].
These relationships are not surprising in light of the remark-
able pharmacological properties exhibited by this protein
[22], but the molecular basis by which HMW adiponectin
exerts its eﬀects are largely unknown. Most studies have
focused on using the full-length protein, which is made up of
multiple oligomers. To best study the mechanism of action
however, as well as to advance its development as a therapeu-
tic, it is necessary to work with discrete and well-characterized
preparations of the HMW complex.
Accordingly, we set out to characterize this protein complex.
Sedimentation equilibrium and electrophoretic studies of
HMW adiponectin from bovine serum and culture of 3T3-L1
adipocytes show that it is octadecameric. Dynamic light scat-
tering experiments and structural studies by transmission elec-
tron microscopy reveal that the HMW oligomer is structurally
similar to C1q.2. Materials and methods
2.1. Puriﬁcation of bovine HMW adiponectin
HMW adiponectin was puriﬁed from calf serum (Hyclone) as
described previously [23,24].
2.2. Sedimentation equilibrium
Experiments were carried out using a Beckman XL-I analytical
ultracentrifuge using 12 mm double sector Epon charcoal-ﬁlled center-
pieces. HMW adiponectin (10 lM in monomer) in phosphate-buﬀered
saline (PBS) pH 7.5 was centrifuged at 5000 rpm or 6000 rpm and
20 C for 18 h prior to measurement of absorbance data. Data were
ﬁt to the following equation [25], that describes the gradient distribu-
tion of a homogeneous species: A ¼ Bþ A0 exp½rðx2  x20Þ, where A is
the absorbance at radius x, A 0 the absorbance at reference radius x0,blished by Elsevier B.V. All rights reserved.
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vin, m the partial speciﬁc volume of adiponectin = 0.712 ml/g based
on the partial speciﬁc volumes of its constituent amino acids (including
hydroxyprolyl residues, see Supplementary Information), four glucos-
ylgalactosyl [24], and two sialic acid moieties [23], q the density of sol-
vent = 1.012 g/ml, x the angular velocity in radians/s, M the apparent
molecular weight, and B the solvent absorbance (blank).
2.3. Dynamic light scattering
Experiments were carried out in a Dynapro Titan dynamic light
scattering instrument (Wyatt Technology Corporation). Data were ac-
quired at 20 C over 10 s, repeated 10 times and averaged. Ten such
acquisitions were performed to give 1000 s of data. The Dynamics soft-
ware was used to ﬁt the autocorrelation function using the cumulants
method, and to extract the diﬀusion coeﬃcient and hydrodynamic
radius. Particles smaller than 0.5 nm were excluded from the calcula-
tion of the percent mass as this signal also was present in the blank
buﬀer.
2.4. Separation of HMW from hexameric and trimeric adiponectin
by ion exchange chromatography
Murine HMW adiponectin from serum-free culture media of 3T3-L1
adipocytes was separated from the other oligomers by batch binding to
DEAE Fast Flow Sepharose (Amersham) at 4 C, followed by elution
with 25 mM Tris pH 8.0 containing 160 mM NaCl.
2.5. Thermal unfolding of murine HMW adiponectin
The oligomer was heated with SDS loading buﬀer at the speciﬁed
temperatures for 10 min prior to SDS–PAGE [15] on a 4–15% Tris–
HCl gel (Bio-Rad) at 150 V. Visualization was achieved by Western
blot using a polyclonal antibody (R&D Systems).Fig. 1. Analysis of bovine HMW adiponectin by analytical ultracentrifugati
with silver staining. (B) Sedimentation equilibrium trace of the puriﬁed com
yielded an apparent molecular weight of 486 kDa. The residuals are shown ab
for comparison.2.6. Transmission electron microscopy of bovine HMW adiponectin
A 10 lM sample of bovine HMW adiponectin in PBS was diluted 9-
fold with 50 mM HEPES containing NaCl (150 mM) and CaCl2. The
sample was applied to a glow-discharged carbon grid for 30 s, blotted
dry then stained with 1% uranyl acetate for 30 s. Images were acquired
using a Philips CM200 FEG transmission electron microscope (TEM)
with a 2k by 2k Tietz CCD camera.3. Results and discussion
3.1. Puriﬁcation of bovine HMW adiponectin
Electrophoretic analysis of the puriﬁed bovine complex with
visualization by silver staining (Fig. 1A) revealed that it runs as
a single band, indicating its high purity. Reduction followed by
denaturation converted the slow running band to a small band
moving at approximately 30 kDa (see Supplementary Informa-
tion). The identities of both bands were veriﬁed to be adipo-
nectin by Western blot analysis.3.2. Bovine HMW adiponectin is an octadecamer
All sedimentation equilibrium experiments, carried out at
5000 rpm and 6000 rpm at 10 lM and 1 lM, respectively, were
consistent with HMW adiponectin being an octadecamer.
Shown in Fig. 1B is a typical trace obtained at 5000 rpm, along
with residuals. All data sets ﬁt best to an ideal single species
model with random residuals (top). The random residuals pro-on. (A) Electrophoretic analysis of puriﬁed bovine HMW adiponectin
plex. The data (circles) were ﬁt using an ideal single species model and
ove the trace. A theoretical curve (bold line) for a dodecamer is shown
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surable equilibrium with other oligomeric states. The apparent
molecular weight, calculated from the average of 10 experi-
ments, was determined to be 485968 kDa, 18.4 ± 1.1 times lar-
ger than the glycosylated monomer (26455 Da). We conclude
that HMW adiponectin is an octadecamer.
3.3. HMW adiponectin from 3T3-L1 adipocytes is an
octadecamer
Fig. 2A shows that murine HMW adiponectin has the same
electrophoretic mobility as the bovine protein. This result sug-
gests that it is also an octadecamer. The two smaller oligomeric
states of murine adiponectin were previously identiﬁed as hex-
amer and trimer by biophysical and imaging methods [5,9].Fig. 2. Murine adiponectin is an octadecamer. (A) HMW adiponectin from 3
Western blot under non-reducing conditions. Lane 1: puriﬁed HMW complex
100, 75, 50 and 37 kDa); Lane 3: bovine HMW adiponectin. (B) Murine HM
reducing loading buﬀer prior to analysis by SDS–PAGE/Western blot. The
weights for the intermediates formed at 90 C (open squares) were interpolate
trimer (closed circles) from conditioned media of 3T3-L1 adipocytes.Thus, knowing that the murine oligomers have 18, 6 and 3 sub-
units, a standard curve (shown in Fig. 2C) was made from
which the masses of intermediates generated by thermal dena-
turation at 90 C (Fig. 2B) were estimated. In this lane, each
intermediate band diﬀered from the next by approximately
55 kDa (Fig. 2C and Table 1), which is the mass of a dimer.
Thus, it appears that thermal denaturation resulted in the gen-
eration of intermediates having 16, 14, 12, 10 or 8 subunits. A
priori, this result is puzzling as the assumed minimal building
block of HMW adiponectin is the trimer. The trimer however,
is a non-covalent complex. Furthermore, disulﬁde bonds are
required for HMW formation [6,9,15]. Since disulﬁde bond-
ing is a covalent interaction, thermal denaturation would
likely disrupt the trimer necessarily leading to loss of dimers.T3-L1 adipocytes and from calf serum were analyzed by SDS–PAGE/
from 3T3-L1 adipocytes; Lane 2: molecular weight markers, (250, 150,
W adiponectin was heated to various temperatures for 10 min in non-
number of subunits in each oligomer are indicated. (C) The molecular
d from a standard curve obtained using the octadecamer, hexamer, and
Fig. 3. Bovine HMW adiponectin has an apparent Stokes radius of 9 nm. (A) The autocorrelation function measured by dynamic light scattering.
The data (circles) were ﬁt by the method of cumulants (line). The residuals are plotted above. (B) Size distribution of particles extracted from the
autocorrelation function. Error bars represent standard deviations from 100 independent measurements.
Table 1
Summary of the molecular weights of thermally denatured intermedi-
ates determined by gel electrophoresis
Distance migrated
(mm)
Molecular weight
(kDa)
Number of
subunits
20.9 419 16
23.6 366 14
26.7 314 12
30.4 261 10
35.9 199 8
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the larger complex.
3.4. HMW adiponectin is asymmetric in shape
Dynamic light scattering measurements gives additional
data regarding the hydrodynamic size of the bovine complex.
The autocorrelation function, shown in Fig. 3A, is monoexpo-
nential as determined by the method of cumulants, [26] with
random residuals, indicating that it is monodisperse and that
there are no other physical processes that are occurring at
detectable levels. The apparent hydrodynamic radius extracted
from the autocorrelation function centers on 9.0 nm (Fig. 3B).
Using the calculated mass of octadecameric adiponectin, the
theoretical size of an anhydrous 485968 Da sphere is however
estimated to be only 5.2 nm [27,28] (see Supplementary Infor-
mation). Thus, HMW adiponectin is asymmetric, which is
expected if it were C1q-like in structure. From the Stoke–
Einstein equation, the ratio of f/f0 is 1.73. Modeled as an
oblate ellipsoid, bovine HMW adiponectin has a maximal
axial ratio = 11.8 with the long axes (2a) of the hydrated form
being 26.8 nm in length and the short axis (2b) is 2.3 nm. The
short axis seems unrealistically small but such an outcome wasalso obtained for C1q [29]. The long axes of the ellipsoid were
comparable to the diameter of the splayed complexes observed
by electron microscopy (2a = 33 nm) but the short axis (2b)
was a mere 2.2 nm in length. Thus, HMW adiponectin seems
to have similar hydrodynamic behavior to C1q.
3.5. HMW adiponectin is structurally similar to C1q
The bouquet-like objects (Fig. 4) observed for bovine HMW
adiponectin by TEM provide additional insight into the struc-
ture of HMW adiponectin beyond prior EM studies [6,9].
First, it is clearly reminiscent of C1q [30–32]. In ﬂattened side
views (bottom row), six globular objects can be seen atop thin
stalks, which presumably correspond to the six trimers on col-
lagen triple helices that are required to form the octadecameric
complex. The stalks bunch together at the other end in a man-
ner that is consistent with the requirement for N-terminal
disulﬁde bonding [6,9,15]. While the disulﬁde-bond pattern
of the complex remains to be elucidated, the overall architec-
ture of HMW adiponectin is highly similar to C1q.
Some of the side views of HMW adiponectin (Fig. 4, middle
row) suggest a conical structure of the oligomer with the C-ter-
minal portion forming the base. Interestingly, these globular
domains are arranged in a tight ring. End-on views of the com-
plex (Fig. 4, top row) also show this arrangement, although
some structures formed a circle of ﬁve globular domains plus
one in the middle. The N-terminal region of the collagen do-
mains sometimes appeared to be bundled together, implying
higher order collagen interactions. Presumably, these interac-
tions help direct the subunits to be parallel and form a closely
packed cone.
The relevance of the oligomeric architecture of adiponectin
to interactions with its receptor remains to be established.
While this complex may possibly bind multiple receptors to
bring about clustering, it is also plausible that the circular
Fig. 4. A montage of transmission electron micrographs of bovine HMW adiponectin. Top row: end views of HMW adiponectin with six globular
heads arranged in a ring. Middle row: Side views of HMW adiponectin that highlight the conical shape of the complex. Bottom row: Side views of
HMW adiponectin that appear ﬂattened but highlight the similarity of the oligomer to C1q. Bar is 9.0 nm.
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actions with a single receptor binding, perhaps in the middle.
Such a mode of binding would not be available to the hexamer
or trimer, and could therefore form the structural basis for dif-
ferential signaling amongst adiponectin oligomers.4. Conclusions
In summary, bovine and murine HMW complexes are octa-
decamers and the bovine adiponectin has a structure analo-
gous to C1q. We are continuing studies to further our
understanding of the relationship between oligomeric structure
and biological activity and to facilitate the development of
speciﬁc adiponectin oligomers as therapeutics to treat meta-
bolic disorders.
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